论文部分内容阅读
目的观察在服用乳酸菌联合复方蛋白酶散治疗小儿肺炎继发性腹泻的临床疗效。方法将医院收治的92例小儿肺炎继发性腹泻患者随即分为观察组和对照组各46例,对照组在对症治疗的基础上使用乳酸菌片治疗,观察组使用乳酸菌片联合复方胃蛋白酶散治疗,然后比较2种疗法的临床效果。结果观察组总有效率为93.47%明显高于对照组的78.26%(P<0.05);观察组腹泻持续时间、肺炎时间、住院时间及起效时间均短于对照组,差异有统计学意义(P<0.05)。结论乳酸菌片联合复方胃蛋白酶散治疗小儿肺炎继发性腹泻疗效确切值得临床大力推广。
Objective To observe the clinical efficacy of lactic acid bacteria combined with compound protease in treating secondary diarrhea in children with pneumonia. Methods 92 cases of children with secondary pneumonia secondary to pneumonia were randomly divided into observation group (46 cases) and control group (46 cases). The control group was treated with lactic acid bacteria on the basis of symptomatic treatment. The observation group was treated with lactic acid bacteria tablets and compound pepsin powder , And then compare the clinical effects of two kinds of therapies. Results The total effective rate in the observation group was 93.47%, which was significantly higher than that in the control group (78.26%, P <0.05). The duration of diarrhea, pneumonia time, hospitalization time and onset time in the observation group were shorter than those in the control group P <0.05). Conclusion lactic acid bacteria tablets combined with pepsin treatment of children with secondary pneumonia secondary diarrhea curative effect worthy of clinical promotion.